More on GMAB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.9 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Genmab A/S (NQ:GMAB)
Delayed: 25.61 +0.34 (1.35%)
Prev. Close $25.27  
Open$25.05 
52 Wk High$ 
52 Wk Low$ 
Day High$25.66 
Day Low$24.88 
P/E N/A  
EPS$ 
Volume1,592,905 

Friends, Peers and Foes (?): GNMSF, GEN:DC, 0MGB, MRUS, JNJ (more...)

Jun 17, 2026 11:30 AM Form 6-K GENMAB A/S For: Jun 17
Jun 16, 2026 03:37 PM Form 6-K GENMAB A/S For: Jun 16
Jun 16, 2026 03:13 PM Capital Increase in Genmab as a Result of Employee Warrant Exercise
Jun 15, 2026 12:09 PM Form 6-K GENMAB A/S For: Jun 15
Jun 15, 2026 12:04 PM Major Shareholder Announcement
Jun 15, 2026 11:08 AM Form 6-K GENMAB A/S For: Jun 15
Jun 11, 2026 01:58 PM Form 6-K GENMAB A/S For: Jun 11
Jun 11, 2026 01:17 PM Grant of Restricted Stock Units and Warrants to Employees in Genmab
Jun 11, 2026 10:46 AM Genmab presents positive EPCORE FL-1 subgroup data for lymphoma treatment
Jun 11, 2026 10:45 AM Genmab Presents EPCORE® FL-1 Subgroup Data Demonstrating Consistent Efficacy and Safety Results for Epcoritamab in Combination with Rituximab and Lenalidomide (R²) Across Relapsed or Refractory (R/R
View All Articles

Entities mentioned with GMAB

View All Entities